Regeneron-Sanofi's Libtayo Scores CHMP's Positive Opinion For Two Advanced Cancer SettingsBenzinga • 05/24/21
Sanofi to showcase data from its transformative oncology pipeline at 2021 ASCO MeetingGlobeNewsWire • 05/19/21
GlaxoSmithKline and Sanofi plan to join vaccine race with booster dosesProactive Investors • 05/17/21
Sanofi, GSK Covid Vaccine Triggers ‘Strong Immune Response' As Firms Aim For Approval Later This YearForbes • 05/17/21
GlaxoSmithKline, Sanofi post positive mid-stage trial results for COVID-19 vaccineProactive Investors • 05/17/21
Sanofi and GlaxoSmithKline say their COVID-19 vaccine triggers a strong immune response, bolstering the late-comer program's potential as a booster shotBusiness Insider • 05/17/21
Sanofi and GSK COVID-19 vaccine candidate demonstrates strong immune responses across all adult age groups in Phase 2 trialGlobeNewsWire • 05/17/21
Sanofi establishes three-year collaboration with Stanford Medicine to accelerate immunology researchPRNewsWire • 05/06/21